Radiogenomics in Renal Cancer Management—Current Evidence and Future ProspectsMatteo Ferro, Octavian Sabin Tătaru, Gennaro Musi et al.|International Journal of Molecular Sciences|2023Cited by 124
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature reviewMatteo Ferro, Octavian Sabin Tătaru, Stefano Luzzago et al.|Therapeutic Advances in Urology|2023Cited by 103
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Biagio Barone et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 56
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin ImmunotherapyMatteo Ferro, Ottavio De Cobelli, Octavian Sabin Tătaru et al.|Diagnostics|2022Cited by 41
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCGRoberto Contieri, Matteo Ferro, Rodolfo Hurle et al.|Minerva Urology and Nephrology|2022Cited by 38